[en] Mebendazole (MBZ) is a carbamate derivative with an aminobenzimidazole structure. It possesses antihelminthic properties and is particularly insoluble in water. In order to increase its aqueous solubility, hydroxpropyl-beta-cyclodextrin (HP-beta-CD) was used in combination with water-soluble polymers (polyvinylpyrrolidone or hydroxypropymethyl cellulose) and different organic acids (citric or tartaric). Increased solubility was observed on heating the mixture. The effects of the time and temperature of the heating process on drug solubility and stability were investigated. The results clearly show that the best conditions for increasing solubility and limiting degradation of MBZ is to heat a combination of MBZ, HP-beta-CD (200 mM), tartaric or citric acid (50 mM) and HPMC (0.1% w/v) in a water-bath at 95degreesC for 60 min. This method increases solubility to about 680 mug/ml and limits degradation to 2.5%.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Alvarez, Covadonga
Van Hees, Thierry ; Université de Liège - ULiège > Département de pharmacie > Pharmacie clinique et pharmacie hospitalière
Piel, Géraldine ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique et magistrale
Liégeois, Jean-François ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Delattre, Luc ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids
Díaz D., Bernard-bernard M.J., Gracia Mora J., Escobar Llanos C.M. (1999) Solubility, 1H-MNR and molecular mechanics of mebendazole with different cyclodextrins. Drug Dev. Ind. Pharm. 25(1):111-115.
Li P., Zhao L., Yalkowsky S.H. (1999) Combined effect of cosolvents and cyclodextrins on solubilization of non-polar drugs. J. Pharm Sci. 88(11):1107-1111.
Yoshida A. (1988) Pharmaceutical evaluation of hydroxyalkylethers of β-CD. Int. J. Pharm. 46:217-222.
Redenti E., Szente L., Szejtli J. (2000) Drug/cyclodextrin/ hydroxyacid multicomponent systems. Properties and pharmaceutical application. J. Pharm. Sci. 89(1):2-8.
Loftsson T., Fridriksdottir H. (1998) The effect of watersoluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163:115-121.
Savolainen J., Jarvlnen K., Taipale H., Jarho P., Loftsson T., Jarvinen T. (1998) Co-administration of a watersoluble polymer increases the usefulness of cyclodextrin in solid oral dosage forms. Pharm. Res., Nov. 15(11):1696-1701.
Piel G., Evrard B., Fillet M., Llabres G., Delattre L. (1998) Development of non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int. J. Pharm. 169:15-22.
Loftsson T. (1998) Increasing the cyclodextrin complexation of drugs and drug bioavailability though addition of water-soluble polymers. Pharmazie 53(11):733-740.
Piel G., Evrard B., Van Hees T., Llabries G., Delattre L. (1999) Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharm. Sci. 9(8):257-260.
